Research Labs at the Healey Center

At the Sean M. Healey and AMG Center for ALS at Mass General, we are committed to radical change and acceleration of converting research into enduring treatments. Find information on our research studies and enroll in clinical trials.
7 results
  • research lab

HEALEY ALS Platform Trial

Borrowing from successes in cancer drug development, the Healey Center and NEALS faculty are leading the first ALS Platform Trial.

  • research lab

Lagier-Tourenne Lab: Clotide Lagier-Tourenne, MD, PHD

Clotilde Lagier-Tourenne performs patient-oriented research to understand the molecular mechanisms driving neurodegeneration in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD) and to develop therapeutic strategies.

  • research lab

Neurological Clinical Research Institute

The Neurological Clinical Research Institute (NCRI) at Mass General is experienced in designing, developing, facilitating, and conducting multicenter clinical trials in Amyotrophic Lateral Sclerosis (ALS) and other neurological diseases.

  • research lab

Wainger Laboratory: Brian Wainger, MD, PhD

The Wainger Lab at Massachusetts General Hospital focuses on how abnormalities of motor and sensory neuron physiology contribute to diseases such as ALS and chronic pain.

Showing 1 - 7 of 7 results